Related Experiment Video

Updated: Mar 24, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses

Ming Yuan1, Eika Webb2, Nicholas Robert Lemoine3,4

  • 1Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK. m.yuan@qmul.ac.uk.

Viruses
|March 10, 2016
PubMed

Insights

The CRISPR-Cas9 system offers an efficient method for editing viral genomes to create novel oncolytic viruses for cancer therapy. This advanced gene-editing tool overcomes limitations of traditional methods, accelerating the development of potent cancer treatments.

Area of Science:

  • Oncolytic virotherapy
  • Gene editing technologies
  • Cancer therapeutics development

Background:

  • Oncolytic viruses represent a promising class of cancer therapeutics with a favorable safety profile.
  • Clinical translation of oncolytic viruses is hindered by complex modifications and limitations in creating potent viral strains.
  • Understanding tumor-virus-host interactions is crucial for developing next-generation oncolytic viruses.

Purpose of the Study:

  • To review the CRISPR-Cas9 system as an efficient method for editing viral genomes.
  • To discuss the application of CRISPR-Cas9 in creating novel oncolytic viruses.
  • To explore future applications and potential challenges of CRISPR-Cas9 in oncolytic virus development.

Main Methods:

  • Review of existing literature on CRISPR-Cas9 gene editing.
  • Analysis of CRISPR-Cas9's application in viral genome modification.
  • Discussion of homologous recombination limitations in oncolytic virus engineering.

Main Results:

  • CRISPR-Cas9 enables precise and efficient editing of viral genomes, surpassing traditional methods like homologous recombination.
  • This system facilitates the creation of engineered oncolytic viruses with enhanced tumor-targeting capabilities and potency.
  • CRISPR-Cas9 also serves as a valuable tool for fundamental research in viral biology.

Conclusions:

  • The CRISPR-Cas9 system is a transformative technology for developing advanced oncolytic viruses.
  • It addresses key challenges in engineering potent and targeted oncolytic agents for cancer therapy.
  • Further research into CRISPR-Cas9 applications and safety is warranted for its clinical integration.
Keywords:
CRISPR-Cas9Herpes simplex virusOncolytic virusVaccinia virusadenovirushomologous recombination

More Related Videos

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

18.4K
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

16.4K

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.5K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.9K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.5K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
7.3K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.2K